Pepdexpepdex
← All compounds

Adderall

Mixed amphetamine salts · Stimulant (amphetamine)

Research reference only. Pepdex does not sell, supply or track this compound, and nothing here is guidance to use it — this page exists so the evidence and the risks are visible.

What it is

Prescription mixed amphetamine salts for ADHD and narcolepsy, and the most widely diverted "study drug" in the US. It reliably increases wakefulness, motivation and confidence in a session of work — which is exactly why its cognitive benefit is overestimated by the people using it.

How it works

Amphetamine works differently from most stimulants: rather than only blocking dopamine and noradrenaline reuptake, it enters the neuron and forces those transmitters out into the synapse. That is why its effects are stronger and its dependence liability higher than a pure reuptake blocker. In ADHD the therapeutic effect comes from raising catecholamine signalling in prefrontal circuits that regulate attention and impulse control. In people without ADHD the same pharmacology produces alertness and drive without a corresponding gain in the things people take it for — and the gap between how well you feel you are working and how well you actually are is one of the more consistent findings in the literature.

What human evidence shows

For diagnosed ADHD, effect sizes are large and the evidence is excellent. For neurotypical enhancement the literature is sobering: objective gains on complex cognition are small to absent, while users consistently RATE their own performance as improved — a documented perception gap. It improves task engagement more than task ability.

The studies, one by one

  • STRONG for short-term reduction of diagnosed ADHD symptoms under medical treatment. The certainty beyond that is weaker than the reputation suggests: a Cochrane review of 19 adult trials found symptom improvement but rated the evidence low to very low, with short follow-up, attrition problems and 16 of the 19 industry-funded.
  • In people WITHOUT ADHD: LIMITED for narrow laboratory endpoints and NONE SHOWN for the academic or occupational outcomes people actually take it for. Reviews find small benefits on selected tasks; a 60-person placebo-controlled trial found no overall composite improvement and possible impairment among those who started out performing best. Neither a universal benefit nor a universal absence of effect is supportable.
  • Several studies find that non-prescribed users rate their performance as improved when objective measures did not change, or got worse.
  • Non-medical use is associated with lower, not higher, academic attainment in observational student data — a correlation that is confounded, but not in the direction the marketing story would predict.
  • Cardiovascular effects are dose-related and real: raised heart rate and blood pressure, with sudden cardiac events reported in people with underlying structural heart disease.

Half-life and how long it lasts

Mixed amphetamine salts, with the instant-release form acting for around four to six hours and the extended-release form roughly ten to twelve. Tolerance to the euphoric and appetite effects develops faster than tolerance to the therapeutic effect in ADHD, which is part of why escalation is a hallmark of misuse rather than of treatment.

Risks

Real dependence potential — this is a Schedule II amphetamine, and tolerance-driven dose escalation is the standard failure mode. Cardiovascular load (heart rate, blood pressure), appetite and sleep destruction, anxiety, and in vulnerable people psychosis at high exposure. Withdrawal is a genuine crash. Combining with other stimulants or MAOIs is dangerous. Counterfeit pills pressed with fentanyl are a documented, recurring cause of death in people who thought they were buying Adderall.

Who should never touch it

  • Anyone with structural heart disease, arrhythmia, cardiomyopathy or a family history of sudden cardiac death
  • Anyone taking an MAO inhibitor
  • Anyone with a history of psychosis, mania or bipolar disorder
  • Anyone with a history of stimulant or other substance dependence
  • Anyone with uncontrolled hypertension or hyperthyroidism
  • Anyone taking it without a diagnosis and a prescriber, which is the entire non-medical case

Interactions worth knowing

  • MAO inhibitors — a genuinely dangerous combination that can cause a hypertensive crisis, and one of the few absolute drug contraindications in this catalogue.
  • Other stimulants including caffeine, clenbuterol and decongestants, which stack cardiovascular load.
  • SSRIs and other serotonergic drugs, where serotonin syndrome is a recognised though uncommon risk.
  • Alcohol, which masks impairment and adds cardiac strain.
  • Thyroid hormone and beta-agonists, on the same cardiovascular reasoning.

Stacking interactions

Documented interactions with other things people research. A compound not listed here does not mean the combination is safe — only that no specific interaction is on file.

CautionClenbuterol

Concurrent exposure to agents with sympathomimetic cardiovascular effects may further increase heart rate, blood pressure, or arrhythmia risk; pair-specific evidence varies.

CautionDMAA

Concurrent exposure to agents with sympathomimetic cardiovascular effects may further increase heart rate, blood pressure, or arrhythmia risk; pair-specific evidence varies.

CautionThyroid hormones (T3 / T4)

Concurrent exposure to agents with sympathomimetic cardiovascular effects may further increase heart rate, blood pressure, or arrhythmia risk; pair-specific evidence varies.

CautionTesofensine

Concurrent exposure to agents with sympathomimetic cardiovascular effects may further increase heart rate, blood pressure, or arrhythmia risk; pair-specific evidence varies.

CautionCaffeine

Concurrent exposure to agents with sympathomimetic cardiovascular effects may further increase heart rate, blood pressure, or arrhythmia risk; pair-specific evidence varies.

What a clinician would watch

  • Blood pressure and resting heart rate, which is standard practice on stimulant treatment.
  • Any cardiac symptom — chest pain, fainting, palpitations — which needs assessment rather than dose adjustment.
  • Sleep, which stimulants degrade and which then degrades everything the drug was meant to improve.
  • Appetite and weight, particularly in younger people.
  • Mood, agitation and any psychotic symptoms, which are recognised and dose-related.
  • Escalation of use, which is the earliest sign that this has stopped being treatment.

What stopping looks like

Stopping after regular use produces a recognised crash: fatigue, heavy sleep, low mood, increased appetite and strong cravings, usually worst in the first few days and easing over one to two weeks. It is not medically dangerous in the way sedative withdrawal is, but the depressive phase can be severe and is when relapse is most likely. Anyone prescribed it for ADHD should not stop abruptly without their prescriber, since the untreated condition returns. Anyone who has been using someone else's prescription and finds stopping hard should treat that as the signal it is.

Myth vs evidence

It makes anyone smarter.

In people without ADHD the measured gains are small and confined to narrow laboratory tasks, with one trial finding possible impairment in the highest baseline performers. What it reliably increases is how productive you feel.

If it calms you down, that proves you have ADHD.

This is folklore. Stimulants improve attention in most people regardless of diagnosis; the response is not a diagnostic test.

Taking it only for exams or deadlines avoids dependence.

Intermittent high-stakes use is a common on-ramp precisely because it pairs the drug with reward. Dependence liability is high by any measure.

Prescribed means safe for anyone.

A prescription follows a cardiac history, a diagnosis and monitoring. Taking someone else's skips all three, and the cardiac screening is the part that matters most.

Legal status

US: Schedule II — possession without a prescription is a felony in most states. There is no legal grey-market version; anything bought outside a pharmacy is either diverted or counterfeit.

Research on this compound

Papers about this compound, not proof of the claims above. A title says what was studied, which is sometimes a negative result or a different question entirely.

  • Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis
  • Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis
  • Effect of amphetamines on blood pressure

Evidence base

A301 research papers
substantial literature

Strong human evidence: either a phase 3 or 4 trial report alongside review-level evidence, or ten or more randomised controlled trial reports.

phase 3/4
0
randomised
37
reviews
6
human trials
46

Counts are of published papers, not distinct trials, and they nest rather than add up: PubMed files every randomised trial as a clinical trial too. They measure how much research exists — not whether this works or is safe for you.

Research (12)

Turn Adderall into a plan that's yours

The info above is free. Membership makes it personal, the Coach answers questions about your exact stack, the Stack tracks it for you, and the Verified Sources shows you how to vet what you buy.

  • AI Coach, ask anything about your stack. It does the dosing math, flags interactions, and tells you what to do next.
  • Personal Stack, save your protocol, track it across devices, log doses, get a heads-up before a vial runs out.
  • Verified Sources, the vetted reference for checking quality and sourcing, members only.
Become a member, from $4.99/week

Cancel anytime · or save with $59.99/yr · Coach + Stack included

Where next